Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupressure vs Iberogast in Children With Functional Nausea
NCT02660970Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Iberogast in functional nausea (4 arms), sponsored by University Hospital Basel. Primary endpoint: Visual Analog Scale for Nausea at 4 weeks. Started Jan 2016; status: completed.
02
Drugs
Iberogast
03
Conditions
functional nausea
Beyond the preview
Go deeper on NCT02660970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660970.